Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$408,330
-$83,664 QoQ
Shares Held
4,500
-6.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,039
of 2,948 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $3,822,274 across 12 Medical Devices names. ABT ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
4,848 | $1,526,344 | |
| 2 | BSX |
Boston Scientific Corp
|
24,524 | $1,046,684 | |
| 3 | MDT |
Medtronic plc
|
8,358 | $653,846 | |
| 4 | ABT |
Abbott Laboratories
This page
|
4,500 | $408,330 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
1,085 | $69,450 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
603 | $51,912 | |
| 7 | EW |
Edwards Lifesciences Corp
|
393 | $35,550 | |
| 8 | DXCM |
Dexcom Inc
|
288 | $19,396 |
All Filings in ABT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $408,330 | 4,500 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $491,994 | 4,792 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $625,698 | 4,994 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $667,021 | 4,980 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $662,368 | 4,870 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $729,044 | 5,496 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $620,521 | 5,486 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $384,783 | 3,375 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $350,384 | 3,372 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $369,963 | 3,255 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $331,310 | 3,010 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $292,099 | 3,016 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $339,270 | 3,112 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $324,335 | 3,203 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $342,105 | 3,116 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $299,956 | 3,100 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $326,927 | 3,009 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $337,917 | 2,855 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $401,812 | 2,855 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $390,892 | 3,309 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $381,757 | 3,293 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $394,633 | 3,293 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $365,039 | 3,334 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $354,568 | 3,258 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $298,153 | 3,261 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $158,214 | 2,005 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||